Culwell Kelly 4
4 · Evofem Biosciences, Inc. · Filed Feb 21, 2020
Insider Transaction Report
Form 4
Culwell Kelly
Chief Medical Officer
Transactions
- Sale
Common Stock
2020-02-19$7.00/sh−1,000$7,000→ 196,226 total
Footnotes (1)
- [F1]These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 25, 2019.